Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Paul Chaplin
Manufacturing
BN reopens facility, works to increase monkeypox vax production
Bavarian Nordic expects to only manufacture Jynneos until around the end of next year, CEO Paul Chaplin said.
Angus Liu
Aug 24, 2022 11:42am
JPM execs speak on 2018: Pricing moves, yes. M&A frenzy, no
Jan 15, 2018 9:38am
After Prostvac flop, Bavarian Nordic showcases RSV data
Sep 25, 2017 2:10pm
Bavarian Nordic posts positive phase 2 for universal RSV shot
Jun 27, 2017 12:49pm